Fecal Short and Branched Chain Acids as Possible Biomarkers for Inflammatory Bowel Disease and UC and CD Subgroups? A Case-Control Study
Fecal SCFAs and BCFAs demonstrated feasibility as biomarkers for IBD. Increased sensitivity and specificity were achieved over fecal calprotectin (FCP) tests between healthy and IBD patients. No useable data was found in the literature to use a validation cohort.
Authors
- Rebecca Bearden (ORCID: https://orcid.org/0000-0001-9342-5304)
- Aria Baniahmad (ORCID: https://orcid.org/0000-0003-1085-9161)
- Justin K. Gray (ORCID: https://orcid.org/0000-0002-7030-5286)
- Buthina Odat
- Baochuan Guo (ORCID: https://orcid.org/0000-0003-1448-0597)
- Nadia A. Abdelkader
Institutions
- Cleveland State University (US)
- Al al-Bayt University (JO)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1097/mcg.0000000000002237
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.81